Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock.

Peak wind gusts in Boulder and possibly other locations along the Front Range don't pack the same punch they used to, ...

Mesa Laboratories, Inc. (NASDAQ:MLAB) develops, designs, manufactures, sells, and services life sciences tools and quality control products and services.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and ...

Mesa Laboratories, Inc. reported strong financial performance for its third fiscal quarter ended December 31, 2024, with total revenues reaching $62.8 million, a 17.5% increase from the previous ...

The access road leading to the National Center for Atmospheric Research Mesa Lab in Boulder will close to the public on July ...

A Mesa biotech medical manufacturer is seeing an uptick in demand for its wound care products, leading to an expansion of its ...

Separately, Wells Fargo & Company decreased their price target on Mesa Laboratories from $120.00 to $100.00 and set an “underweight” rating on the stock in […] ...

MESA LABORATORIES ($MLAB) posted quarterly earnings results on Tuesday, February 4th. The company reported earnings of $2.67 per share, beating estimates of $1.78 by ...

Mesa Laboratories Stock Performance. Shares of MLAB stock opened at $126.37 on Friday. The firm has a 50 day moving average of $119.48 and a two-hundred day moving average of $126.43. The stock ...

Mesa Laboratories' recent acquisition of GKE has improved ROICs, but the legacy business remains a drag on overall performance. Despite improvements, MLAB's valuation risks compression, trading at ...